scholarly article | Q13442814 |
P356 | DOI | 10.1110/PS.03172703 |
P953 | full work available at URL | https://europepmc.org/articles/pmc2366915?pdf=render |
https://europepmc.org/articles/PMC2366915 | ||
https://europepmc.org/articles/PMC2366915?pdf=render | ||
https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1110%2Fps.03172703 | ||
https://onlinelibrary.wiley.com/doi/pdf/10.1110/ps.03172703 | ||
P932 | PMC publication ID | 2366915 |
P698 | PubMed publication ID | 14500876 |
P5875 | ResearchGate publication ID | 9087712 |
P2093 | author name string | Leo C. James | |
Dan S. Tawfik | |||
P2860 | cites work | Basic local alignment search tool | Q25938991 |
The catalytic reaction and inhibition mechanism of Drosophila alcohol dehydrogenase: observation of an enzyme-bound NAD-ketone adduct at 1.4 A resolution by X-ray crystallography | Q27618570 | ||
Convergent solutions to binding at a protein-protein interface | Q27621452 | ||
Generation of hybridomas secreting murine reaginic antibodies of anti-DNP specificity | Q70645433 | ||
Role of conserved amino acid residues in the complementarity determining regions on hapten-antibody interaction of anti-(4-hydroxy-3-nitrophenyl) acetyl antibodies | Q71523056 | ||
Conformational diversity and protein evolution--a 60-year-old hypothesis revisited | Q73702393 | ||
Antibody multispecificity mediated by conformational diversity | Q27640592 | ||
Antibody fragment Fv4155 bound to two closely related steroid hormones: the structural basis of fine specificity | Q27742018 | ||
Immune versus natural selection: antibody aldolases with enzymic rates but broader scope | Q27748677 | ||
Catalytic promiscuity and the evolution of new enzymatic activities | Q28140063 | ||
Catalytic and binding poly-reactivities shared by two unrelated proteins: The potential role of promiscuity in enzyme evolution | Q28364533 | ||
Immunology. Isomeric antibodies | Q31133797 | ||
Molecular basis for the binding promiscuity of an anti-p24 (HIV-1) monoclonal antibody | Q32163518 | ||
Mycoplasma-pneumoniae-induced thrombotic thrombocytopenic purpura | Q33332662 | ||
Moonlighting proteins. | Q33543960 | ||
Anatomy of the antibody molecule | Q34060425 | ||
Antigenic mimicry, clonal selection and autoimmunity. | Q34239696 | ||
Molecular mimicry and immune-mediated diseases | Q34474075 | ||
Enzymes with extra talents: moonlighting functions and catalytic promiscuity | Q35114457 | ||
Heavy chain variable region contribution to the NPb family of antibodies: somatic mutation evident in a gamma 2a variable region | Q36630020 | ||
Evidence for multispecificity of antibody molecules | Q39450994 | ||
Theoretical studies of clonal selection: Minimal antibody repertoire size and reliability of self-non-self discrimination | Q39588499 | ||
The enzyme-linked immunosorbent assay (ELISA) (theory, technique and applications) | Q40984988 | ||
Idiotypic selection of an antibody mutant with changed hapten binding specificity, resulting from a point mutation in position 50 of the heavy chain. | Q41975432 | ||
Generation of a catalytic antibody by site-directed mutagenesis | Q42196280 | ||
Structural analysis of antibody specificity. Detailed comparison of five Fab'-steroid complexes | Q42600166 | ||
Mechanism of allergic cross-reactions—I. Multispecific binding of ligands to a mouse monoclonal anti-DNP IgE antibody | Q44278936 | ||
Wild isolates of murine cytomegalovirus induce myocarditis and antibodies that cross-react with virus and cardiac myosin | Q45753788 | ||
Mechanism of chymotrypsin. Structure, reactivity, and nonproductive binding relationships | Q48012245 | ||
Mouse immunoglobulin allotypes: multiple differences between the nucleic acid sequences of the IgEa and IgEb alleles | Q48331464 | ||
Conformational changes affect binding and catalysis by ester-hydrolysing antibodies. | Q52035910 | ||
A tyrosyl-tRNA synthetase recognizes a conserved tRNA-like structural motif in the group I intron catalytic core | Q62984045 | ||
The basics of binding: mechanisms of antigen recognition and mimicry by antibodies | Q70608186 | ||
P433 | issue | 10 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | biochemistry | Q7094 |
antibody | Q79460 | ||
purpurin | Q116472 | ||
furazolidone | Q2467555 | ||
acenaphthenequinone | Q2739953 | ||
alizarin | Q267813 | ||
anthrone | Q411768 | ||
anthraquinone | Q423174 | ||
3,4-dihydroxy-9,10-dioxo-9,10-dihydroanthracene-2-sulfonic acid | Q27104468 | ||
2,6-dihydroxyanthraquinone | Q27115942 | ||
anthrarufin | Q27117170 | ||
6-(4-hydroxy-3-nitrobenzamido)hexanoic acid | Q27123947 | ||
N(6)-(2,4-dinitrophenyl)lysine | Q27123948 | ||
N(6)-(2,4-dinitrophenyl)-L-lysine | Q27123949 | ||
N-(2,4-dinitrophenyl)serine | Q27123952 | ||
N-(2,4-dinitrophenyl)-L-serine | Q27123953 | ||
N-(2,4-dinitrophenyl)proline | Q27123955 | ||
N-(2,4-dinitrophenyl)-L-proline | Q27123956 | ||
6-(4-hydroxy-5-iodo-3-nitrobenzamido)hexanoic acid | Q27123957 | ||
alizarin complexone | Q27123958 | ||
4-bromo-1-hydroxyanthraquinone-2-carboxylic acid | Q27123959 | ||
Hydrophobic and Hydrophilic Interactions | Q70685039 | ||
hydrophobicity | Q41854968 | ||
P304 | page(s) | 2183-2193 | |
P577 | publication date | 2003-10-01 | |
P1433 | published in | Protein Science | Q7251445 |
P1476 | title | The specificity of cross-reactivity: promiscuous antibody binding involves specific hydrogen bonds rather than nonspecific hydrophobic stickiness | |
The specificity of cross‐reactivity: Promiscuous antibody binding involves specific hydrogen bonds rather than nonspecific hydrophobic stickiness | |||
P478 | volume | 12 |
Q35092533 | A targeted quantitative proteomics strategy for global kinome profiling of cancer cells and tissues |
Q28755595 | Analogies between digital radio and chemical orthogonality as a method for enhanced analysis of molecular recognition events |
Q92538007 | Anti-Myelin Proteolipid Protein Peptide Monoclonal Antibodies Recognize Cell Surface Proteins on Developing Neurons and Inhibit Their Differentiation |
Q38242657 | Antibodies for immunolabeling by light and electron microscopy: not for the faint hearted |
Q91808144 | Antibody Structure and Function: The Basis for Engineering Therapeutics |
Q33259491 | Antibody binding loop insertions as diversity elements |
Q26801316 | Antibody promiscuity: Understanding the paradigm shift in antigen recognition |
Q51746811 | BODIPY(®) FL histamine as a new modality for quantitative detection of histamine receptor upregulation upon IgE sensitization in murine bone marrow-derived mast cells. |
Q30379344 | Back to the Future: Nuclear Magnetic Resonance and Bioinformatics Studies on Intrinsically Disordered Proteins. |
Q28474495 | Beauty is in the eye of the beholder: proteins can recognize binding sites of homologous proteins in more than one way |
Q33284945 | Binding induced conformational changes of proteins correlate with their intrinsic fluctuations: a case study of antibodies |
Q36254449 | Computer-aided antibody design |
Q27658806 | Contribution of Asparagine Residues to the Stabilization of a Proteinaceous Antigen-Antibody Complex, HyHEL-10-Hen Egg White Lysozyme |
Q31172558 | Cross-reactivity and conformational multiplicity of an anti-polycyclic aromatic hydrocarbon mAb |
Q36141544 | Cytokinergic IgE Action in Mast Cell Activation |
Q35820537 | Defining the complementarities between antibodies and haptens to refine our understanding and aid the prediction of a successful binding interaction. |
Q39351354 | Design of a heterotetravalent synthetic allergen that reflects epitope heterogeneity and IgE antibody variability to study mast cell degranulation |
Q37041529 | Directed evolution of streptavidin variants using in vitro compartmentalization |
Q30399262 | Dynamic New World: Refining Our View of Protein Structure, Function and Evolution |
Q34197530 | Expanding the proteome: disordered and alternatively folded proteins |
Q33480594 | Exploring functional roles of multibinding protein interfaces |
Q64229272 | HIV-1 anchor inhibitors and membrane fusion inhibitors target distinct but overlapping steps in virus entry |
Q35556797 | Highly specific off-target binding identified and eliminated during the humanization of an antibody against FGF receptor 4. |
Q27644089 | How much can a T-cell antigen receptor adapt to structurally distinct antigenic peptides? |
Q26864217 | Hydrophobicity and charge shape cellular metabolite concentrations |
Q35969898 | Immunopotentiating properties of a multispecific α-anti-idiotype antibody |
Q33619565 | Immunoprevalence to Six Waterborne Pathogens in Beachgoers at Boquerón Beach, Puerto Rico: Application of a Microsphere-Based Salivary Antibody Multiplex Immunoassay |
Q37552198 | Inhibition of weak-affinity epitope-IgE interactions prevents mast cell degranulation |
Q37417488 | Interaction of C1q with IgG1, C-reactive protein and pentraxin 3: mutational studies using recombinant globular head modules of human C1q A, B, and C chains |
Q36698606 | Interrogation of sphingosine-1-phosphate receptor 2 function in vivo reveals a prominent role in the recovery from IgE and IgG-mediated anaphylaxis with minimal effect on its onset |
Q36828393 | Ligase-4 Deficiency Causes Distinctive Immune Abnormalities in Asymptomatic Individuals |
Q35477596 | Mechanism of the antigen-independent cytokinergic SPE-7 IgE activation of human mast cells in vitro |
Q37405719 | Molecular Mechanism and Energy Basis of Conformational Diversity of Antibody SPE7 Revealed by Molecular Dynamics Simulation and Principal Component Analysis |
Q54549089 | Multiple drugs and multiple targets: an analysis of the electrostatic determinants of binding between non-nucleoside HIV-1 reverse transcriptase inhibitors and variants of HIV-1 RT. |
Q36775969 | Non-canonical binding of an antibody resembling a naïve B cell receptor immunoglobulin to hepatitis B virus capsids. |
Q64245263 | On the Lipophilic Nature of Autoreactive IgE in Chronic Spontaneous Urticaria |
Q30532713 | Peptide-conjugation induced conformational changes in human IgG1 observed by optimized negative-staining and individual-particle electron tomography |
Q37951868 | Polyreactive antibodies in adaptive immune responses to viruses |
Q38957602 | Promiscuous antibodies characterised by their physico-chemical properties: From sequence to structure and back |
Q37389046 | Protein promiscuity and its implications for biotechnology |
Q46074569 | Protein promiscuity: drug resistance and native functions--HIV-1 case |
Q36168340 | Proteomics-on-a-chip: the challenge to couple lab-on-a-chip unit operations |
Q99564857 | Pyruvate dehydrogenase complex-enzyme 2, a new target for Listeria spp. detection identified using combined phage display technologies |
Q36819928 | Regulation of the mast cell response to the type 1 Fc epsilon receptor. |
Q36301775 | Specificity in molecular design: a physical framework for probing the determinants of binding specificity and promiscuity in a biological environment. |
Q37002818 | Specificity of T-cell alloreactivity |
Q30476133 | Structure and kinetics of a transient antibody binding intermediate reveal a kinetic discrimination mechanism in antigen recognition |
Q27683622 | Substrate Deconstruction and the Nonadditivity of Enzyme Recognition |
Q34373086 | Synthetic allergen design reveals the significance of moderate affinity epitopes in mast cell degranulation. |
Q28295483 | The 'evolvability' of promiscuous protein functions |
Q57814568 | The BackMAP Python module: how a simpler Ramachandran number can simplify the life of a protein simulator |
Q42419120 | The promise of the anti-idiotype concept. |
Q93089001 | Visitors to a Tropical Marine Beach Show Evidence of Immunoconversions to Multiple Waterborne Pathogens |
Search more.